NCT02932098

Brief Summary

Purpose: The purpose of this study will be to test the use of a web-based mobile application (app) initiated at the time of hospital discharge to engage and monitor patients in order to efficiently deliver better outcomes. The mobile app will be used to remind patients of discharge instructions, assess adherence treatment regimens, and evaluate symptoms. Rationale: Approximately 60% of patients with ovarian cancer have advanced stage disease at diagnosis, and thus aggressive surgical procedures are often medically necessary. Recent evidence suggests that nearly one in five patients hospitalized for ovarian cancer surgery will be readmitted within 30 days of discharge. Patients readmitted within 30 days have a 50% increase in one-year mortality rates and significantly increased costs of care. In addition, many of the conditions and complications that led to readmission could potentially have been avoided with more intensive post-surgical follow-up care. Mobile health technologies can effectively and efficiently connect patients with their healthcare team and have been shown to improve treatment adherence and reduce avoidable ER visits and hospitalizations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2016

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 11, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 13, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

June 26, 2018

Status Verified

October 1, 2016

Enrollment Period

11 months

First QC Date

October 11, 2016

Last Update Submit

June 22, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improve quality of life (SF-12)

    The primary data analysis will adhere to the intention-to-treat principle and in the final analysis, the participants will be categorized according to their initial randomization. Investigators will measure changes in quality of life from baseline and at 30-days, and compare changes between the two study arms.

    30 days

Secondary Outcomes (2)

  • Reduce re-admission and emergency department visits to the hospital within 30-days of discharge

    30 days

  • Activities of daily living, status 30 days after discharge

    30 days

Study Arms (2)

App Notifications

EXPERIMENTAL

The web-based app will be used to remind patients of discharge instructions, ask questions related to current prescription pain medication use, new symptoms, or changes in the severity of symptoms. Patients will receive reminders via text or email to use the app. Daily reminders will be sent in Week 1, every other day in Week 2, and once per week for Weeks 3-4. All participants will be followed for a minimum of 30 days and will be asked to complete a baseline survey at enrollment and a follow-up survey scheduled 30 days after hospital discharge.

Behavioral: Discharge instructions remindersBehavioral: Prompts to report symptoms via the web-enabled appBehavioral: Clinical Alerts

Usual Care

ACTIVE COMPARATOR

Patients will have access to the web-based app, but will not receive reminders to use it. All participants will be followed for a minimum of 30 days and will be asked to complete a baseline survey at enrollment and a follow-up survey scheduled 30 days after hospital discharge.

Behavioral: Clinical Alerts

Interventions

Week 1, Day 1: Click through each discharge instruction; Week 1, Days 2-7: Click through single list of all discharge instructions. Participants will receive a reminder of discharge instructions everyday for the first week post-discharge.

App Notifications

Group will receive reminders to enter new symptoms or changes in symptoms (based on a Likert scale or Y/N) on the following schedule: Week 1 (daily), Week 2 (every other day), Weeks 3-4 (once per week)

App Notifications
Clinical AlertsBEHAVIORAL

Alerts based on certain response thresholds are generated to inform the patient's care team of any concerning responses or trends that emerge from the patient reported outcomes. These alerts will inform providers of particular patient-related adverse events or symptoms requiring an intervention prior to the point that emergent medical care is needed. Information in the alert emails will include the participant's Medical Reference Number (MRN), initials, date of birth, and details about the symptom(s) that generated the alert. Pod nurses instructed to respond to any clinical alerts (sent via email) as soon as possible following standard of care.

App NotificationsUsual Care

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult female patients (age≥18)
  • Diagnosed (or suspected) of ovarian, fallopian, or primary peritoneal cancer (any stage)
  • Scheduled for open abdominal surgery for cancer diagnosis and/or staging during recruitment period
  • Have a mobile device with a data plan or a home computer with Internet
  • Have a valid email address
  • Willing to complete brief symptom reports on the app in the 30 days following hospital discharge

You may not qualify if:

  • Unable to communicate in English
  • A concomitant diagnosis of endometrial or breast cancer
  • Did not have open abdominal surgery for a hysterectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

West Cancer Center, DESOTO, 7668 Airways Blvd.

Southaven, Mississippi, 38671, United States

Location

West Cancer Center, MIDTOWN, 1588 Union Ave.

Memphis, Tennessee, 38104, United States

Location

West Cancer Center, EAST MEMPHIS, 7945 Wolf River Blvd

Memphis, Tennessee, 38138, United States

Location

MeSH Terms

Conditions

Genital Neoplasms, Female

Condition Hierarchy (Ancestors)

Urogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Ilana Graetz, PhD

    University of Tennessee

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2016

First Posted

October 13, 2016

Study Start

August 1, 2016

Primary Completion

July 1, 2017

Study Completion

March 1, 2018

Last Updated

June 26, 2018

Record last verified: 2016-10

Locations